These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. 4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques. Huang A; Young TL; Dang VT; Shi Y; McAlpine CS; Werstuck GH Atherosclerosis; 2017 Nov; 266():103-112. PubMed ID: 29024862 [TBL] [Abstract][Full Text] [Related]
25. Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions. Thiem K; Hoeke G; Zhou E; Hijmans A; Houben T; Boels MG; Mol IM; Lutgens E; Shiri-Sverdlov R; Bussink J; Kanneganti TD; Boon MR; Stienstra R; Tack CJ; Rensen PC; Netea MG; Berbée JF; van Diepen JA Diab Vasc Dis Res; 2020; 17(1):1479164119892140. PubMed ID: 31868000 [TBL] [Abstract][Full Text] [Related]
26. Roles for endothelial cell and macrophage Gch1 and tetrahydrobiopterin in atherosclerosis progression. Douglas G; Hale AB; Patel J; Chuaiphichai S; Al Haj Zen A; Rashbrook VS; Trelfa L; Crabtree MJ; McNeill E; Channon KM Cardiovasc Res; 2018 Aug; 114(10):1385-1399. PubMed ID: 29596571 [TBL] [Abstract][Full Text] [Related]
27. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781 [TBL] [Abstract][Full Text] [Related]
28. The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo. Boyanovsky B; Zack M; Forrest K; Webb NR Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):532-8. PubMed ID: 19164803 [TBL] [Abstract][Full Text] [Related]
33. Deletion of fibroblast activation protein provides atheroprotection. Stein S; Weber J; Nusser-Stein S; Pahla J; Zhang HE; Mohammed SA; Oppi S; Gaul DS; Paneni F; Tailleux A; Staels B; von Meyenn F; Ruschitzka F; Gorrell MD; Lüscher TF; Matter CM Cardiovasc Res; 2021 Mar; 117(4):1060-1069. PubMed ID: 32402085 [TBL] [Abstract][Full Text] [Related]
34. Myeloid β-Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. Wang F; Liu Z; Park SH; Gwag T; Lu W; Ma M; Sui Y; Zhou C Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1468-1478. PubMed ID: 29724817 [TBL] [Abstract][Full Text] [Related]
35. Artemisinin Attenuated Atherosclerosis in High-Fat Diet-Fed ApoE-/- Mice by Promoting Macrophage Autophagy Through the AMPK/mTOR/ULK1 Pathway. Cao Q; Du H; Fu X; Duan N; Liu C; Li X J Cardiovasc Pharmacol; 2020 Apr; 75(4):321-332. PubMed ID: 31895870 [TBL] [Abstract][Full Text] [Related]
36. Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis. Aarup A; Pedersen TX; Junker N; Christoffersen C; Bartels ED; Madsen M; Nielsen CH; Nielsen LB Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1782-90. PubMed ID: 27444197 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis. Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730 [TBL] [Abstract][Full Text] [Related]
38. Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice. van Kampen E; Beaslas O; Hildebrand RB; Lammers B; Van Berkel TJ; Olkkonen VM; Van Eck M PLoS One; 2014; 9(10):e109024. PubMed ID: 25347070 [TBL] [Abstract][Full Text] [Related]